Evidence map›Paper›PMID 41251327›Full record

ArticleMedical mycology2025

Management of mould pneumonia in resource-limited settings in Asia: A Delphi-based consensus statement by the Asia Fungal Working Group.

Methee Chayakulkeeree, Ban Hock Tan, Yee-Chun Chen, Atul Patel, Ruoyu Li, Ariya Chindamporn, Mitzi Chua, Kauser Jabeen, Nguyen Phu Huong Lan, Lee Lee Low and 4 more

Abstract readConsensus Statement
In one paragraph

Article in Medical mycology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Methee ChayakulkeereeDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0002-4582-4914
Ban Hock TanDepartment of Infectious Diseases, Singapore General Hospital, 169608, Singapore.ORCID 0000-0002-1458-9456
Yee-Chun ChenDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City 100, Taiwan.ORCID 0000-0002-1816-9010
Atul PatelInfectious Diseases Clinic, Vedanta Institute of Medical Sciences, Navarangpura, Ahmedabad 380009, India.ORCID 0000-0003-2859-0025
Ruoyu LiDepartment of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Centre for Skin and Immune Diseases, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing 100034, China.ORCID 0000-0002-2302-3577
Ariya ChindampornDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-9761-1670
Mitzi ChuaDepartment of Microbiology and Parasitology, Cebu Institute of Medicine, Cebu City 6000, Philippines.ORCID 0009-0002-2645-2462
Kauser JabeenDepartment of Pathology & Laboratory Medicine, Aga Khan University, Karachi 74800, Pakistan.ORCID 0000-0003-2497-7847
Nguyen Phu Huong LanHospital for Tropical Diseases, Ho Chi Minh City 700000, Vietnam.
Lee Lee LowDepartment of Medicine, Hospital Sultanah Bahiyah, Alor Setar 05460, Kedah, Malaysia.ORCID 0009-0003-7446-9434
Pei-Lun SunDepartment of Dermatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 33302, Taiwan.ORCID 0000-0002-9868-4628
Retno WahyuningsihDepartment of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.ORCID 0000-0002-1888-0806
Li-Ping ZhuDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200051, China.ORCID 0000-0002-3098-7307
Arunaloke ChakrabartiDoodhadhari Burfani Hospital and Research Institute, Haridwar, Uttarakhand 249410, India.ORCID 0000-0003-1555-3807

Funding

Gilead Sciences
6 · The paper itself

Abstract

Mould pneumonia can be life-threatening, and its incidence is increasing in Asia. Due to significant variability in diagnostic setups and the availability of antifungal agents, especially in resource-limited settings, the current treatment practices and recommendations for local clinicians are poorly described. This study aimed to develop a consensus statement on the clinical management of mould pneumonia in Asia, particularly within resource-limited settings. Clinicians and infectious disease experts from the Asia Fungal Working Group answered questions about the regional epidemiology as well as diagnostic and resource-limited treatment approaches of mould pneumonia. Guided by a literature review, 22 initial questions were generated and voted upon anonymously using a Delphi-based methodology with predefined consensus criteria. The study comprised two rounds: one to generate summary statements based on the panelists' questionnaire responses, and the other to review, confirm and rate the level of agreement of the consensus statements using a five-point Likert scale. The panelists generated 21 summary statements on the epidemiology (5), diagnosis (8), and treatment (8) of mould pneumonia, 20 of which achieved ≥ 70% consensus. Through a consensus-building exercise, clinical experts from Asia developed a set of 21 consensus statements for the diagnosis and management of mould pneumonia in resource-limited settings.

Indexed as

Antifungal AgentsPneumoniaAsiaConsensusDelphi TechniqueDisease ManagementFungiHealth ResourcesHumansResource-Limited SettingsSurveys and QuestionnairesAntifungal Agentsantifungal agentsaspergillosismucormycosispneumoniarespiratory tract infections

Identifiers

PMID41251327
PMCPMC12666386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.